← Back to all trials
Completed
NCT06068257
Tumor-Derived FGF19
Conditions: Colorectal Cancer, Breast Cancer, Healthy
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: Yes
Enrollment: 119
Sponsor: University of Central Florida
Location: Burnett School Biomedical Sciences Orlando Florida
Summary
Identify and test thresholds, specificity and sensitivity for a potential cancer associated biomarker protein, FGF19, (and associated markers) for detection in human blood in the blood of breast and colorectal in cancer patients, and see if occurs at higher rates than healthy controls
Eligibility Criteria
Inclusion Criteria:
* The study will enroll adult persons with breast cancer or colorectal cancer or no cancer (healthy controls) who are able to do a fasting blood draw.
(Pregnant women may choose to be in the study. The study procedures do not pose a risk to the safety of the unborn child or the woman.)
Exclusion Criteria:
* The study will not enroll persons who are unable or unwilling to provide informed consent.
* Adults unable to consent, individuals who are not yet adults, and prisoners will be excluded from this study.
Source: ClinicalTrials.gov (NCT06068257). StuddyBuddy aggregates publicly available trial information.
